Severe COVID-19-related encephalitis can respond to immunotherapy

Brain. 2020 Dec 1;143(12):e102. doi: 10.1093/brain/awaa337.
No abstract available

Publication types

  • Letter
  • Kommentar

MeSH terms

  • Anti-N-Methyl-D-Aspartate Receptor Encephalitis* / therapy
  • COVID-19*
  • Humans
  • Immunotherapy
  • Laboratories
  • Neurology*
  • SARS-CoV-2